NeurAxis (NRXS) Institutional Ownership $2.20 +0.05 (+2.33%) Closing price 03/11/2025 04:00 PM EasternExtended Trading$2.23 +0.03 (+1.36%) As of 03/11/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for NeurAxis (NASDAQ:NRXS)CurrentInstitutional OwnershipPercentage11.77%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$354.43KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$23.50K Get NRXS Insider Trade Alerts Want to know when executives and insiders are buying or selling NeurAxis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Remove Ads NeurAxis Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Citadel Advisors LLC47,094$111K0.0%N/A0.656% 2/13/2025 Bank of Montreal Can139,017$327K0.0%-6.7%1.936% 1/22/2025 Parsons Capital Management Inc. RI116,726$274K0.0%+797.9%1.672% 1/22/2024 Parsons Capital Management Inc. RI13,000$35K0.0%N/A0.246% (Data available from 1/1/2016 forward)Remove Ads NRXS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NRXS shares? During the previous two years, the following institutional investors and hedge funds held shares of NeurAxis shares: Bank of Montreal Can ($327K), and Parsons Capital Management Inc. RI ($274K), Citadel Advisors LLC ($111K).Learn more on NRXS's institutional investors. What percentage of NeurAxis stock is owned by institutional investors? 11.77% of NeurAxis stock is owned by institutional investors. Learn more on NRXS's institutional investor holdings. Which institutional investors have been buying NeurAxis stock? The following institutional investors have purchased NeurAxis stock in the last 24 months: Parsons Capital Management Inc. RI ($116.73K), and Citadel Advisors LLC ($47.09K). How much institutional buying is happening at NeurAxis? Institutional investors have bought a total of 163,820 shares in the last 24 months. This purchase volume represents approximately $389.14K in transactions. Which NeurAxis major shareholders have been selling company stock? The following institutional investors have sold NeurAxis stock in the last 24 months: Bank of Montreal Can ($10K). How much institutional selling is happening at NeurAxis? Institutional investors have sold a total of 10,000 shares in the last 24 months. This volume of shares sold represents approximately $23.50K in transactions. Related Companies Alpha Pro Tech Major Shareholders Cytosorbents Major Shareholders Safe Pro Group Inc. Common Stock Major Shareholders Apyx Medical Major Shareholders Inovio Pharmaceuticals Major Shareholders Microbot Medical Major Shareholders CollPlant Biotechnologies Major Shareholders Daxor Major Shareholders Outset Medical Major Shareholders Femasys Major Shareholders This page (NASDAQ:NRXS) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersFormer CIA to Trump – Will you Shut down this secret lab?Deep in the sands of New Mexico lies a government lab so secret it makes Area 51 look like a tourist spot… ...Paradigm Press | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMarch 18th: Gold SHOCK? On March 18th, an event is taking place that could completely shock the market. Stocks could go ballistic…...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredMusk’s real agenda in Washington… In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...Porter & Company | SponsoredDeFi Coin on Verge of Breakout!We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years. Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeurAxis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeurAxis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.